3/14/2026 4:49:31 AM | Browse: 0 | Download: 0
| Publication Name | World Journal of Nephrology |
|---|---|
| Manuscript ID | 117173 |
| Country | India |
|
2025-12-01 03:18 | ||
|---|---|---|---|
|
2025-12-01 03:18 | ||
|
2025-12-24 10:15 | ||
|
2025-12-24 10:15 | ||
|
2026-01-02 15:04 | ||
|
|||
|
2026-01-26 02:47 | ||
|
|||
|
2026-01-26 10:47 | ||
|
2026-01-26 10:47 | ||
|
|||
|
2026-02-28 03:32 | ||
|
2026-03-14 04:49 |
| ISSN | 2220-6124 (online) |
|---|---|
| Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright | The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 |
| Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 |
| Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website | http://www.wjgnet.com |
| Category | Urology & Nephrology | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Manuscript Type | Retrospective Study | ||||||||||||||||||||||||||
| Article Title | Efficacy of finerenone in reducing proteinuria in diabetic kidney disease with maximum tolerable doses of dapagliflozin and telmisartan | ||||||||||||||||||||||||||
| Manuscript Source | Invited Manuscript | ||||||||||||||||||||||||||
| All Author List | Amit S Pasari, Sushrut Gupta, Prasad Gurjar, Vishal Ramteke, Sunny Malde, Twinkle Pawar, Vijay Jeyachandran, Pranjal Kashiv, Shubham Dubey, Mohit Kurundwadkar, Kapil Sejpal, Charulata Bawankule, Nishant Deshpande and Manish Ramesh Balwani | ||||||||||||||||||||||||||
| ORCID |
|
||||||||||||||||||||||||||
| Funding Agency and Grant Number | |||||||||||||||||||||||||||
| Corresponding Author | Vishal Ramteke, MD, Department of Nephrology, Max Super Speciality Hospital, Mankapur Square , Koradi Road, Nagpur 440030, Mahārāshtra, India. vvramteke@gmail.com | ||||||||||||||||||||||||||
| Key Words | Diabetic nephropathy; Finerenone; Proteinuria; Albuminuria; Dapagliflozin; Urinary albumin-to-creatinine ratio; chronic kidney disease | ||||||||||||||||||||||||||
| Core Tip | Diabetic nephropathy is the leading cause of end-stage renal disease worldwide and proteinuria reduction is the cornerstone in the management. In some patients even with dual therapy with renin-angiotensin-aldosterone system blockers and sodium-glucose co-transporter-2 inhibitors, residual proteinuria persists. Finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist has shown results reducing albuminuria and slowing chronic kidney disease progression. This study evaluated the additive effect of finerenone exclusively in patients receiving maximum tolerable doses of both dapagliflozin and telmisartan unlike previously available studies evaluating its effect on patients with maximum tolerated dose of angiotensin receptor blocker alone. | ||||||||||||||||||||||||||
| Publish Date | 2026-03-14 04:49 | ||||||||||||||||||||||||||
| Citation | Pasari AS, Gupta S, Gurjar P, Ramteke V, Malde S, Pawar T, Jeyachandran V, Kashiv P, Dubey S, Kurundwadkar M, Sejpal K, Bawankule C, Deshpande N, Balwani MR. Efficacy of finerenone in reducing proteinuria in diabetic kidney disease with maximum tolerable doses of dapagliflozin and telmisartan. World J Nephrol 2026; 15(1): 117173 |
||||||||||||||||||||||||||
| URL | https://www.wjgnet.com/2220-6124/full/v15/i1/117173.htm | ||||||||||||||||||||||||||
| DOI | https://dx.doi.org/10.5527/wjn.v15.i1.117173 |
| Full Article (PDF) | WJN-15-117173-with-cover.pdf |
|---|---|
| Manuscript File | 117173_Auto_Edited_080250.docx |
| Answering Reviewers | 117173-answering-reviewers.pdf |
| Audio Core Tip | 117173-audio.ogg |
| Biostatistics Review Certificate | 117173-biostatistics-statement.pdf |
| Conflict-of-Interest Disclosure Form | 117173-conflict-of-interest-statement.pdf |
| Copyright License Agreement | 117173-copyright-assignment.pdf |
| Signed Informed Consent Form(s) or Document(s) | 117173-informed-consent-statement.pdf |
| Institutional Review Board Approval Form or Document | 117173-institutional-review-board-statement.pdf |
| Non-Native Speakers of English Editing Certificate | 117173-non-native-speakers.pdf |
| Peer-review Report | 117173-peer-reviews.pdf |
| Scientific Misconduct Check | 117173-scientific-misconduct-check.png |
| Scientific Editor Work List | 117173-scientific-editor-work-list.pdf |
| CrossCheck Report | 117173-crosscheck-report.pdf |